TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Jacomm /Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 8,602 | 8,953 | 8,803 |
Financial expenses | 54 | 27 | 30 |
Earnings before taxes | -148 | 591 | 268 |
EBITDA | -105 | 622 | 306 |
Total assets | 3,620 | 3,558 | 3,376 |
Current assets | 3,587 | 3,550 | 3,360 |
Current liabilities | 2,305 | 1,403 | 1,520 |
Equity capital | 678 | 1,463 | 1,084 |
- share capital | 34 | 33 | 36 |
Employees (average) | 3 | 3 | 3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 18.7% | 41.1% | 32.1% |
Turnover per employee | 2,867 | 2,984 | 2,934 |
Profit as a percentage of turnover | -1.7% | 6.6% | 3.0% |
Return on assets (ROA) | -2.6% | 17.4% | 8.8% |
Current ratio | 155.6% | 253.0% | 221.1% |
Return on equity (ROE) | -21.8% | 40.4% | 24.7% |
Change turnover | -397 | 863 | 321 |
Change turnover % | -4% | 11% | 4% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.